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Abstract
Objective—A strong therapeutic alliance has been found to predict psychotherapeutic treatment
success across a variety of therapeutic modalities and patient populations. However, only a few
studies have examined therapeutic alliance as a predictor of psychotherapy outcome among cancer
survivors, and none have examined this relation in telephone administered cognitive behavioral
therapy (T-CBT). This study evaluated the extent to which therapeutic alliance affected
psychotherapy outcomes in survivors of hematopoietic stem cell transplantation (HSCT), a
treatment for some cancers.
Methods—Forty-six patients enrolled in a randomized clinical trial of T-CBT for posttraumatic
stress disorder (PTSD) completed a baseline assessment (including self-report measures of PTSD
symptoms, depression, and general distress), 10 individual T-CBT sessions, and follow-up
assessments at 6, 9, and 12 months post-baseline. Therapeutic alliance was assessed after the third
T-CBT session with the Working Alliance Inventory, which yields overall and subscale (task,
bond, and goal) scores.
Results—Analyses revealed that higher total therapeutic alliance scores prospectively predicted
decreased depressive symptomatology; higher task scores predicted decreased overall distress,
depressive symptomatology, symptoms of re-experiencing, and avoidance; and higher bond scores
predicted decreased depressive symptomatology and symptoms of re-experiencing.
Conclusions—These results suggest that assessments of therapeutic alliance should be
incorporated into routine clinical care, and therapeutic alliance should be specifically cultivated in
interventions to maximize psychotherapeutic benefits involving vulnerable populations such as
cancer survivors.
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Therapeutic alliance is an established reliable predictor of successful therapy across patient
populations and treatment modalities (e.g., Horvath & Symonds, 1991), including cognitive
and behavioral (Waddington, 2002) and short-term dynamic (Crits-Christoph & Connolly,
1999) therapies. Benefits of a strong therapeutic alliance occur in face-to-face therapy, as
well as therapies delivered over the phone or via the Internet (e.g., Cook & Doyle, 2004;
Klein et al., 2009; Knaevelsrud & Maercker, 2007).
Despite increasing use of various psychotherapies to improve cancer patients’ quality of life
(e.g., Baik & Adams, 2011), studies of therapeutic alliance in therapies used with this
population are limited (for a review, see Schnur & Montgomery, 2010). The present study
evaluated the role of therapeutic alliance in telephone-administered cognitive-behavioral
therapy (T-CBT) for the treatment of posttraumatic stress disorder (PTSD) symptoms in
hematopoietic stem cell transplantation (HSCT) survivors. PTSD is experienced by a
substantial proportion of HSCT survivors (Mosher et al., 2009), and often involves feelings
of detachment from others, which may impede the ability to form a solid therapeutic
alliance. The randomized trial (Duhamel et al., 2010) found that, compared to survivors in
an assessment-only control group, those who completed T-CBT reported fewer illness-
related PTSD symptoms, including less avoidance and fewer intrusive thoughts, as well as
less general distress and fewer depressive symptoms. These benefits were maintained over a
12 month follow-up period. The present study examined the role of therapeutic alliance in
these outcomes. We hypothesized that survivors who completed T-CBT would have greater
decreases in PTSD symptoms, depressive symptoms, and general distress if they had high
rather than low therapeutic alliance.
Method
Participants
Participants had HSCT 1–3 years prior to enrollment, were ≥ 18 years old, fluent in English,
and had significant distress as measured by one of the following: (1) probable illness-related
PTSD on the PTSD Checklist-Civilian Version (PCL-C); (2) subclinical PTSD symptoms as
indicated by scores ≥ 1 standard deviation above the PCL-C mean; or (3) general distress
with some PTSD symptoms, indicated by scores exceeding the clinical cutoff on any two
subscales of the Brief Symptom Inventory (BSI; Derogatis, 1993) or the BSI Global
Severity Index, with PCL-C scores exceeding the cutoff for at least one PTSD symptom
cluster. Participants were excluded if they were waiting for transplant, receiving treatment
for disease relapse, had active psychosis, severe cognitive impairment, substance
dependence, or reported suicidal ideation.
Measures
Background Information—Sociodemographic and medical data were gathered via self-
report and chart review.
General distress and depressive symptoms often co-occur with PTSD (Stuber, Nader,
Yasuda, Punoos, & Cohen, 1991). They were measured using the BSI (Derogatis, 1993), a
well-validated 53-item self-report measure. The Global Severity Index (GSI) and the
depression subscale were used in this study.
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Illness-related PTSD symptoms were assessed with the well-validated PCL-C (DuHamel et
al., 2004; Weathers et al., 1993), a 17-item self-report measure that yields a total score and
four subscale scores for re-experiencing, avoiding, numbing and hyperarousal. The parent
trial (DuHamel et al., 2010) found significant changes due to T-CBT for re-experiencing and
avoiding, and therefore analyses in the current study examined these two subscales.
Therapeutic alliance was assessed with the Working Alliance Inventory Short Form (WAI-
S; Horvath & Greenberg, 1989), a valid, brief version of the original 36-item measure that
consists of 12 items, with four items assessing each of three (task, bond, goal) subscales.
Procedure
Participants were recruited from Memorial Sloan-Kettering Cancer Center, Mount Sinai
Medical Center, and Hackensack University Medical Center. Potential participants provided
verbal consent and completed a screening interview over the phone. Eligible participants
completed a baseline phone interview that included a PTSD diagnostic interview and
measures of PTSD, general distress, and depressive symptoms. Participants were then
randomized to either assessment only or T-CBT (10 sessions of a manualized intervention,
delivered over 10–16 weeks), which included education about HSCT or illness-related
PTSD, self-monitoring and alteration of maladaptive beliefs, guided exposure to cues
associated with PTSD symptoms, enhancement of social support through communication
skills, and relaxation training. (For a more detailed description, see DuHamel et al., 2010.)
Therapeutic alliance was assessed after the third T-CBT session (Tracey & Kokotovic,
1989). PTSD, general distress, and depressive symptoms were re-assessed in follow-up
phone interviews at 6, 9 and 12 months after the baseline assessment.
Statistical Analysis
A linear mixed model was used to evaluate the relation between therapeutic alliance (the
WAI-S overall score, as well as the task, bond, and goal subscales) and general distress (the
BSI-GSI), depressive symptoms (the BSI depression subscale), and PTSD symptoms (the
PCL-C re-experiencing and avoiding subscales). Mean comparisons were Tukey adjusted
for multiple comparisons.
Results
Of the 408 survivors assessed, 81 met study eligibility and 46 were randomized and
completed T-CBT, the follow-up assessments and the assessment of therapeutic alliance.
Their demographic characteristics are shown in Table 1. Most participants were male (n =
28, 60.9%), White (n = 38, 82.6%), and married or cohabitating (n = 37, 80.4%). Most had
been diagnosed with multiple myeloma or amyloidosis (n = 18, 39%) or acute or chronic
myeloid leukemia (n = 10, 21.7%). Participants had undergone HSCT an average of 2.6
years prior to this study.
Descriptive statistics for the WAI are presented in Table 2. As shown, average scores on all
domains were high and close to the maximum possible score for the measure.
Linear mixed model results are presented in Tables 3 and 4. These analyses examined
changes in outcomes that occurred after the baseline assessment. (Changes between
screening and baseline cannot be attributed to the intervention or the therapeutic
relationship.)
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General distress and therapeutic alliance
The overall model examining the interaction between time of assessment and WAI-Task
scores on general distress was marginally significant. However, general distress decreased
significantly between baseline (M = 46.51) and the 6-month (M = 27.16) and 12-month (M
= 12.65) assessments for participants with high WAI-Task scores. General distress
decreased significantly between baseline (M = 42.0) and the 9-month assessment (M =
26.78) for participants with low WAI-Task scores.
Depressive symptoms and therapeutic alliance
The overall model examining the interaction between time of assessment and WAI Total
scores on depressive symptoms was marginally significant. However, there were significant
decreases in depressive symptoms between baseline (M = 4.70) and the 6- (M = 2.73), 9- (M
= 3.29) and 12-month assessments (M = 2.64) for participants with high WAI Total scores.
Depressive symptoms decreased significantly between baseline (M = 5.06) and the 9-month
assessment (M = 2.51) for participants with low WAI Total scores. There was also a
significant interaction between time of assessment and WAI Task scores. For participants
with high WAI Task scores, depressive symptoms decreased between baseline (M = 6.01)
and the 6- (M = 2.61), 9- (M = 3.49), and 12-month assessments (M = 2.38). Finally, there
was a significant interaction between time of assessment and WAI Bond scores. For
participants with high WAI Bond scores, depressive symptoms decreased significantly
between baseline (M = 6.01) and the 6- (M = 2.73) 9- (M = 3.46), and 12-month
assessments (M = 2.70). For participants with low WAI Bond scores, there was a significant
decrease in depressive symptoms between baseline (M = 4.77) and the 9-month assessment
(M = 2.29). Notably, participants with lower WAI Bond scores had much higher initial
depressive symptoms (M = 7.07) than participants with high WAI Bond scores (M = 4.72).
PTSD symptoms and therapeutic alliance
There was a significant interaction between time of assessment and WAI Task scores on re-
experiencing. Participants with high WAI Task scores had a significant decrease in re-
experiencing between baseline (M = 10.16) and the 6-month assessment (M = 8.27). There
was also a significant interaction between time of assessment and WAI Bond scores on re-
experiencing. Participants with high WAI Bond scores had a significant decrease in re-
experiencing between baseline (M = 9.64), the 6- (M = 7.93) and the 12-month assessment
(M = 6.61). Finally, there was a significant interaction between time of assessment and WAI
Task scores on avoiding. Participants with low WAI Task scores had significant decreases in
avoiding between baseline (M = 3.36) and the 12-month assessment (M = 2.62).
Discussion
To our knowledge, this is the first study to demonstrate a strong therapeutic alliance in
telephone-administered CBT for the treatment of PTSD among cancer survivors. This
finding adds to the growing body of literature indicating that a therapeutic alliance may be
established in telephone and Internet-based therapies (e.g., Cook & Doyle, 2002;
Knaevesrud & Maerker, 2007). Although the advantages and disadvantages of such
therapies have been debated, recent studies consistently report that the benefits conferred by
in-person treatment can be derived via alternative media (e.g., Andrews, Davies, & Titov,
2011; Kilfedder et al., 2010).
Average ratings of alliance were high despite participants’ posttraumatic symptoms and the
challenging nature of our exposure-based treatment. In light of the challenges of retaining
such medically ill patients in face-to-face therapy (Applebaum et al., 2011), the ability to
create a therapeutic alliance in T-CBT is a particularly important finding. HSCT patients
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often experience debilitating physical symptoms as a result of their disease and/or treatment
and may find it challenging to travel to and from treatment centers and to attend
psychotherapy visits in addition to medical appointments. These are the same patients for
whom psychotherapy is of particular importance because of their well-documented
psychological adjustment problems—including PTSD symptoms (e.g., Mosher et al., 2009).
Global distress and therapeutic alliance—Participants who agreed with their
therapists about the tasks needed to accomplish the goals of the intervention had significant
decreases in the intensity of their overall stress levels earlier than those who were less
aligned with their therapist about these tasks. CBT is very task-oriented, and sessions and
homework assignments are often devoted to teaching and practicing specific skills (i.e., how
to restructure a maladaptive thought). A useful avenue for future research would be to
investigate whether participants with high WAI-Task scores are more likely to engage
actively in in-session exercises and to complete homework assignments, and whether they
believe more strongly in the utility of these activities.
Depressive symptoms and therapeutic alliance—Significant decreases in
depressive symptoms over the course of the intervention and follow-up period occurred
earlier for participants with high therapeutic alliance. High overall alliance indicates that
participants were aligned with their therapists on the goals of the intervention and agreed
with them about tasks needed to accomplish these goals, in addition to having positive
feelings about their relationship. Any or all of these components may have contributed to the
observed improvement in depressive symptoms. For instance, they may have maximized the
benefits of in-session and assigned homework in cognitive restructuring, exposure, and
communication. Initial higher depressive symptoms among participants with low WAI-Bond
scores may have hindered development of a therapeutic alliance, potentially explaining the
delayed decrease in depressive symptoms among these survivors. They may have been less
able to engage in the therapeutic relationship, more pessimistic about achieving future-
oriented therapy outcomes, and less aligned with their therapist’s future-oriented goals, all
of which may have translated into lower perceived alliance.
PTSD symptoms and therapeutic alliance—There was a significant reduction in
PTSD symptoms over the course of the intervention and follow-up period. Completion of
tasks such as systematic desensitization and exposure are key therapeutic elements that help
mitigate the re-experiencing of traumatic events. Active completion of these tasks, both in
session and via homework, may partially explain why participants with high WAI-Task
scores had significant decreases in these symptoms whereas those with low WAI-Task
scores did not. Additionally, participants with high WAI-Bond scores had significant
decreases in re-experiencing between baseline and the 6- and 12-month assessments. They
may have felt a greater sense of trust in their therapists than participants with low WAI-
Bond scores, which may have facilitated completion of anxiety-provoking tasks such as
exposure to feared stimuli. Indeed, there is evidence that a strong therapeutic alliance may
motivate patients to engage in treatment-related activities (e.g., Treasure et al., 1999).
Limitations
Several limitations of this study should be acknowledged. Although there is evidence that
assessments of alliance early in therapy are the best indicators of final outcome (e.g.,
Horvath, 1981), the WAI was not re-administered after the third session, and thus we lack
information regarding the stability of participants’ ratings or the impact of changes in
alliance on outcomes. This information would have allowed us to speak to the stability of
alliance over time in telephone-administered CBT. Additionally, the small size of this
study’s sample, as well as the under-representation of ethnic minorities and exclusion of
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those who lacked English fluency, limits our findings’ generalizability. However, there is
evidence that this sample’s racial/ethnic composition is reflective of the population of HSCT
recipients (e.g., Joshua et al., 2010; Rini et al., 2011), and economically disadvantaged
patients may be underrepresented in HSCT populations because they may lack the financial
resources evaluated during the pre-transplant screening process (Hamadani, Craig, Awan, &
Devine, 2010). Regardless of these findings, however, future studies should attempt to enroll
more diverse samples. Finally, it has been suggested that in CBT, the WAI subscales may
tap into a general alliance factor as opposed to unique task, bond, and goal factors (e.g.,
Tracey & Kokotovic, 1989). Although the WAI is currently the “gold standard” measure of
alliance, when interpreting the results of this study it is important to bear in mind the
limitations of the measure, as well as the state of the science of research on the therapeutic
alliance.
Conclusions
This study underscores the potential to establish a strong therapeutic alliance early in
telephone-administered CBT for HSCT survivors and the beneficial role played by alliance
in clinically significant decreases in general distress, and symptoms of depression and
PTSD. These results emphasize the capacity of therapeutic modalities other than face-to-
face therapy to engender a strong therapeutic alliance, and suggest that all aspects of the
alliance—task, bond, and goal—are critical to successful therapeutic outcomes for HSCT
survivors. They also support a more flexible application of traditional psychotherapeutic
interventions for medically ill patients with distress who may be too ill to travel to treatment
centers for face-to-face therapy, and for patients who may be avoidant of treatment centers
due to their PTSD symptoms. Future studies are needed to provide additional support for use
of telephone and Internet-based therapies with patients with a variety of cancer diagnoses
(i.e., type, stage). Further, evaluations of the alliance should eventually be incorporated into
routine clinical care to maximize the benefits of psychotherapy, particularly for such
vulnerable populations as HSCT survivors.
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Table 1
Sociodemographic and Clinical Characteristics of Study Participants (N = 47)
Number of Participants %
Sex
 Male 28 60.9
 Female 18 39.1
Ethnicity
 African American 2 4.4
 White 38 82.6
 Hispanic 3 6.5
 Other 3 6.5
Marital Status
 Married or equivalent 37 80.4
 Divorced 1 2.2
 Other 8 17.4
Education
 High school or less 8 17.4
 Some college 8 17.4
 College/graduate degree 30 65.2
Income
 Less than 19,999 5 10.9
 20,000–39,999 2 4.4
 40,000–59,999 7 15.2
 60,000–79,999 6 13.0
 Greater than 80,000 25 54.3
 Missing 1 2.2
Disease status
 Free of disease 25 54.3
 Alive with disease 13 28.3
 Missing 8 17.4
Transplantation type
 Autologous 27 58.7
 Allogenic 17 37.0
 Missing 2 4.3
GVHD
 Chronic GVHD 2 4.4
 History of acute GVHD 3 6.6
Hospitalization after discharge, months
 0 17 37.0
 1–2 15 32.6
 3–4 6 13.0
 4+ 1 2.2
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Number of Participants %
 Missing 7 15.2
Disease type
 Non-Hodgkin’s lymphoma 7 15.2
 Hodgkin’s lymphoma 3 6.5
 Acute and chronic myeloid leukemia 10 21.7
 Myelodysplastic syndrome or myeloproliferative disease 5 11.0
 Multiple myeloma or amyloidosis 18 39.1
 Missing 3 6.5
Mean Standard Deviation Range
Age, years 52.33 10.6 27–71
Time since transplantation, years 22.62 7.03 13–36
*
Note. GVHD (graft-versus-host disease).
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Table 2
Descriptive Statistics for the Working Alliance Inventory – Short Form
Mean Standard Deviation Range
WAI Total Score 72.54 9.64 42 – 84
WAI Task Subscale 24.07 3.70 10 – 28
WAI Bond Subscale 24.73 3.41 12 – 28
WAI Goal Subscale 23.6 3.75 15 – 28
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Table 3
Interaction of WAI and time on BSI scores between baseline and follow-up assessments
Measure F t P value
BSI-GSI*WAI Task 2.12 .0962
High WAI Task
 Baseline and 6 months 3.86 .0036
 Baseline and 9 months 3.18 .0225
 Baseline and 12 months 5.31 .0001
Low WAI Task
 Baseline and 6 months 2.38 .1437
 Baseline and 9 months 3.66 .0064
 Baseline and 12 months 2.55 .0996
BSI-DEP*WAI Total 2.24 .0850
High WAI Total
 Baseline and 6 months 4.12 .0019
 Baseline and 9 months 3.52 .0100
 Baseline and 12 months 3.60 .0081
Low WAI Total
 Baseline and 6 months 2.18 .2120
 Baseline and 9 months 3.91 .0035
 Baseline and 12 months 2.13 .2306
BSI-DEP*WAI Task 5.11 .0021
High WAI Task
 Baseline and 6 months 4.40 .0007
 Baseline and 9 months 3.12 .0262
 Baseline and 12 months 4.40 .0007
Low WAI Task
 Baseline and 6 months 1.06 .8245
 Baseline and 9 months 2.71 .0709
 Baseline and 12 months 0.81 .9253
BSI-DEP*WAI Bond 5.09 .0024
High WAI Bond
 Baseline and 6 months 4.02 .0026
 Baseline and 9 months 3.18 .0243
 Baseline and 12 months 3.45 .0015
Low WAI Bond
 Baseline and 6 months 1.90 .3340
 Baseline and 9 months 4.24 .0013
 Baseline and 12 months 1.80 .3913
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Table 4
Interaction of WAI and time on PCLC scores between baseline and follow-up assessments
Measure F t P value
PCLC-RE
Time*WAI Task 3.31 .0201
High WAI Task
 Baseline and 6 months 3.77 0.0048
 Baseline and 9 months 2.58 0.0955
 Baseline and 12 months 2.55 0.1007
Low WAI Task
 Baseline and 6 months 1.10 0.8062
 Baseline and 9 months 0.92 0.8870
 Baseline and 12 months 1.33 0.6769
PCL-C-RE *WAI Bond 2.88 .0371
High WAI Bond
 Baseline and 6 months 4.18 .0017
 Baseline and 9 months 2.27 .1779
 Baseline and 12 months 3.31 .0176
Low WAI Bond
 Baseline and 6 months 1.72 .4439
 Baseline and 9 months 1.03 .8408
 Baseline and 12 months 2.65 .0835
PCL-C-AVOID*WAI Task 3.39 .0181
High WAI Task
 Baseline and 6 months 1.40 .6288
 Baseline and 9 months 1.72 .4334
 Baseline and 12 months 2.77 .0623
Low WAI Task
 Baseline and 6 months 2.14 .2248
 Baseline and 9 months 2.78 .0612
 Baseline and 12 months 3.07 .0305
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